Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

A refresher on herpes zoster, current status on vaccination, and the role of the dermatologist.

Guenther LC, Lynde CW.

J Cutan Med Surg. 2011 Jul-Aug;15(4):185-91. Review.

PMID:
21781624
2.

Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.

Johnson RW.

Aging Clin Exp Res. 2009 Jun;21(3):236-43. Review.

PMID:
19571648
3.

Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.

Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O.

BMC Health Serv Res. 2013 Sep 26;13:359. doi: 10.1186/1472-6963-13-359.

4.

[Herpes zoster in old adults].

Lang PO, Belmin J, Michel JP.

Presse Med. 2009 Apr;38(4):571-83. doi: 10.1016/j.lpm.2008.05.019. Epub 2008 Nov 22. Review. French.

PMID:
19028069
5.

Herpes zoster: diagnostic, therapeutic, and preventive approaches.

Bader MS.

Postgrad Med. 2013 Sep;125(5):78-91. doi: 10.3810/pgm.2013.09.2703. Review.

PMID:
24113666
6.

Vaccination against herpes zoster in developed countries: state of the evidence.

Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Mansi JA, Brisson M.

Hum Vaccin Immunother. 2013 May;9(5):1177-84. doi: 10.4161/hv.23491. Epub 2013 Jan 16. Review.

7.

Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.

Tseng HF, Lewin B, Hales CM, Sy LS, Harpaz R, Bialek S, Luo Y, Jacobsen SJ, Reddy K, Huang PY, Zhang J, Anand S, Bauer EM, Chang J, Tartof SY.

J Infect Dis. 2015 Oct 15;212(8):1222-31. doi: 10.1093/infdis/jiv244. Epub 2015 Jun 1.

8.

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Pellissier JM, Brisson M, Levin MJ.

Vaccine. 2007 Nov 28;25(49):8326-37. Epub 2007 Oct 17.

PMID:
17980938
9.

National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine.

Hurley LP, Harpaz R, Daley MF, Crane LA, Beaty BL, Barrow J, Babbel C, Marin M, Steiner JF, Davidson A, Dickinson LM, Kempe A.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S216-23. doi: 10.1086/522153.

PMID:
18419400
10.

[Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].

Marino MG, Bagnato B, Torella I, Franco E.

Ig Sanita Pubbl. 2009 May-Jun;65(3):299-311. Italian.

PMID:
19629155
11.

Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.

Marin M, Yawn BP, Hales CM, Wollan PC, Bialek SR, Zhang J, Kurland MJ, Harpaz R.

Hum Vaccin Immunother. 2015;11(5):1157-64. doi: 10.1080/21645515.2015.1016681.

12.

The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.

Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T.

BMC Med. 2010 Jun 21;8:37. doi: 10.1186/1741-7015-8-37.

13.

Herpes zoster and postherpetic neuralgia: prevention and management.

Fashner J, Bell AL.

Am Fam Physician. 2011 Jun 15;83(12):1432-7.

14.

Herpes zoster (shingles) and postherpetic neuralgia.

Sampathkumar P, Drage LA, Martin DP.

Mayo Clin Proc. 2009 Mar;84(3):274-80. doi: 10.1016/S0025-6196(11)61146-4. Review.

15.

Stop shingles in its tracks.

Lang PO, Hasso Y, Michel JP.

J Fam Pract. 2009 Oct;58(10):531-4.

PMID:
19874731
16.

The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.

Brisson M, Pellissier JM, Camden S, Quach C, De Wals P.

Hum Vaccin. 2008 May-Jun;4(3):238-45. Epub 2010 May 25.

PMID:
18382137
17.

[Prevention of herpes zoster by vaccination].

Kofoed K, Rønholt F, Gerstoft J, Sand C.

Ugeskr Laeger. 2011 Jan 10;173(2):110-4. Review. Danish.

PMID:
21219841
18.

Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review.

Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ.

Vaccine. 2014 Mar 26;32(15):1645-53. doi: 10.1016/j.vaccine.2014.01.058. Epub 2014 Feb 15. Review.

PMID:
24534737
19.

[Herpes zoster and post-herpetic neuralgia in older adults].

Lang PO, Zarate-Lagunes M, Pautex S.

Rev Med Suisse. 2008 Nov 5;4(178):2398-402, 2404. Review. French.

PMID:
19051627
20.

The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine.

Schmader K, Gnann JW Jr, Watson CP.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S207-15. doi: 10.1086/522152. Review.

PMID:
18419399

Supplemental Content

Support Center